WO2023187826 - METHOD TO PURIFY AN ANTIBODY COMPOSITION
National phase entry is expected:
Publication Number
WO/2023/187826
Publication Date
05.10.2023
International Application No.
PCT/IN2023/050300
International Filing Date
29.03.2023
Title **
[English]
METHOD TO PURIFY AN ANTIBODY COMPOSITION
[French]
PROCÉDÉ DE PURIFICATION D'UNE COMPOSITION D'ANTICORPS
Applicants **
DR. REDDY’S LABORATORIES LIMITED
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500034, IN
Inventors
PUPPALA, Anitha
Flat no. 301, Srujanalayam ApartmentPlot No. 356, Bhagya Nagar Colony Phase-3,
Near HMT Hills, Pragathi Nagar Road, JNTU, Kukatpally
Hyderabad, Telangana 500085, IN
MANOREY, Prachi
Flat 202, A-Block, Shubh Labh Twins, Opposite Bombay Hospital, Chikitsak Nagar, Scheme no. 94 EB
Indore, Madhya Pradesh 452010, IN
DUNGA, Kumaraswamy
House No.3-80/A, Navanambadu (Village), Ponnam (Post), Srikakulam (District)
Srikakulam, Andhra Pradesh 532185, IN
JAHAGIRDAR, Kishore Jahagirdar
101, Surya Chandra Satya Enclave, ASR Raju Nagar, Miyapur
Hyderabad, Telangana 500049, IN
Priority Data
202241018822
30.03.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 938 | |
| EPO | Filing, Examination | 6447 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2635 |
Total: 11126 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The method disclosed in the current invention is used to purify an antibody from process and product related impurities. The method discloses the use of affinity chromatography, cation exchange chromatography and mixed-mode chromatography for the reduction of process and product-related impurities. More specifically, the method discloses the use of cation exchange chromatography for the reduction of impurities such as high molecular weight aggregates and charge variants from an antibody composition.[French]
Le procédé décrit dans la présente invention est utilisé pour purifier un anticorps à partir d'impuretés associées à un produit et à un processus. Le procédé décrit l'utilisation d'une chromatographie d'affinité, d'une chromatographie d'échange de cations et d'une chromatographie en mode mixte pour la réduction des impuretés liées au produit et au processus. Plus spécifiquement, le procédé décrit l'utilisation d'une chromatographie d'échange de cations pour la réduction d'impuretés telles que des agrégats de poids moléculaire élevé et des variants de charge à partir d'une composition d'anticorps.